Life Science Vision Capital (LSV), a UK-based venture studio firm, plans to invest $70 million in Indian life science startups and healthcare, media reports said.
It is reported that the company will also establish an office in India’s Silicon Valley, Bangalore to understand the startup ecosystem of India.
Shu Joshi, Managing Partner, LSV Capital, told the media, “We have a corpus of $70 million for an India-specific fund. We are committed to growing our presence in the Indian market, building collaborations with domestic healthcare and life science leaders.”
LSV plans to open its office in India early next year and designate a hire senior-level associates in life sciences to join the firm. The latest investment has already received a commitment of nearly half of the corpus.
The firm has been investing in the country remotely since last year. Moreover, it has rolled out a global digital healthcare and medtech accelerator by partnering with Aster DM Healthcare and Social Alpha.
Mr Joshi added that the company has witnessed the greatest hurdles in life sciences or digital healthcare startups’ journey as they scale from local success to global challenges, and then when they go on to become category leaders.
Life Science Vision Capital has been thriving in the past few years. The firm has supported experienced and entrepreneurial executives to create industry-leading companies. The company has seen success mainly because of organisational strength, workforce, GTM partnerships and commitments from global investors.